ADB is committed to achieving a prosperous, inclusive, resilient, and sustainable Asia and the Pacific, while sustaining its efforts to eradicate extreme poverty.
Established in 1966, it is owned by 68 members—49 from the region.
ORGANIZATION
ACCOUNTABILITY
ADB supports projects in developing member countries that create economic and development impact, delivered through both public and private sector operations, advisory services, and knowledge support.
Cook Islands and ADB
ADB supports the Cook Islands in strengthening resilience against climate and economic shocks and in its recovery from the COVID-19 pandemic.
ADB COVID-19 Response: Cook Islands
ADB's COVID-19 Response is a $20 billion package to support its developing member countries in countering the severe macroeconomic and health impacts caused by COVID-19, including $2.5 billion in concessional and grant resources, as well as $2 billion earmarked for the private sector (nonsovereign).
The Asia Pacific Vaccine Access Facility (APVAX) is ADB's $9 billion vaccine initiative offering rapid and equitable support to its developing member countries as they procure and deliver effective and safe COVID-19 vaccines.
Committed Amount is the financing approved by ADB's Board of Directors or Management for which the legal agreement has been signed by the borrower, recipient, or the investee company and ADB.
*The number of projects excludes short-term finance transactions under the Trade Finance, Supply Chain Finance, and Microfinance Programs.
COVID-19 News and Multimedia: South Pacific
In the News
- ADB, Fiji Sign $3 Million Grant to Prepare for Tourism Upswing
- ADB Provides $10 Million Grant to Help Samoa Manage COVID-19
- ADB Announces $1 Million Grant to Help Tonga Respond to COVID-19
- ADB Provides $8 Million Grant to Help Kiribati Respond to Its First Outbreak of COVID-19
- ADB, UNICEF Send Fiji Urgent Medical Supplies to Battle Second Wave of COVID-19
Blogs and Articles
COVID-19 Publications and Documents
Adult Vaccination in Asia and the Pacific: Policies, Financial Needs, and Fiscal Impacts
Immunization is one of the most cost-effective tools for improving health and well-being. The coronavirus disease (COVID-19) pandemic illustrated the importance of having a well-functioning vaccination delivery system that can deliver vaccines to all population groups.
Gendered Impacts of the COVID-19 Pandemic in Central and West Asia: Lessons Learned and Opportunities for Gender-Responsive Public Investments
Examining how the livelihoods, health, and well-being of women in Central and West Asia were disproportionately affected by the pandemic, this report assesses responses and considers how the experience can guide gender mainstreaming.
Open for Business: How Maldives Overcame the COVID-19 Crisis
The pandemic’s devastating impact on tourism-dependent Maldives highlighted the need to diversify its economy to reduce macroeconomic instability and insulate it against future shocks.
The Race to Manufacture COVID-19 Vaccines: Emerging Vaccine Technologies
Detailing how Australia’s Therapeutics Goods Administration conducted horizon scanning for new vaccines during the pandemic to assist ADB, this report is designed to help countries in Asia and the Pacific prepare for future outbreaks.